A portable device can detect the presence of certain types of cancer in people's breath. Tested on patients, the new device was developed in part by EPFL researchers as part of an international collaboration.
NIBIB-funded researchers have developed a highly effective sensor system to improve the quality of clinical breast examinations by physicians. The training system addresses a critical need for physicians to develop the technique and skill necessary to consistently detect the presence of breast lesions during a clinical breast exam (CBE).
Fullpower® today announced it has been awarded another important patent covering key practical aspects of monitoring human activity, specifically identifying motion states of the user.
It's common to hear complaints about our near-constant connection to our smart phones, but University of Connecticut researchers believe the ubiquity of these devices could lead to better screening for depression.
Intellirod Spine, a medical device company developing novel wireless sensing technologies for use in spinal care, has entered into licensing and distribution agreements with X-spine Systems, Inc. to utilize X-spine Fortex® implants in conjunction with Intellirod's forthcoming LOADPRO™ disposable microelectronic sensor.
Pharmaco-Kinesis Corporation (PKC) announced today that it will develop innovative cloud-linked biosensors in partnership with the Ohio Clinical Trials Collaborative (OCTC) of Ohio. This undertaking seeks to transform medical practice away from reactive medicine to proactive prevention through real time, continuous cloud-linked monitoring driven by PKC's innovative SMART (Simultaneous Multiplexed Automated Real Time Telemedicine) platform.
A multi-disciplinary team of scientists at GE Global Research, the technology development arm for GE, have combined a stunning array of sensing and analytical capabilities, including motion analysis, thermal profiling, image classification/segmentation, 3D object reconstruction, and vapor detection into a single medical sensing device to assess and monitor the progression of pressure ulcers, or bed sores.
An agreement was reached today between Ensocare and New Jersey-based iMPak Health to include iMPak’s innovative medication management system, Kraken, as part of the Ensocare sales portfolio. Ensocare will serve as an authorized re-seller for the Kraken system, which may be sold alone or, in the future, as an integrated feature inside of Ensocare’s Sync and Connect software engines.
Engineers at Oregon State University have used “additive manufacturing” to create an improved type of glucose sensor for patients with Type 1diabetes, part of a system that should work better, cost less and be more comfortable for the patient.
While headlines recently surged over big organizations such as Intel, Apple, and the Michael J. Fox Foundation partnering to launch pilot studies on wearables, mobile apps, and big data for Parkinson's disease... a small, Cleveland, Ohio based company continued to do what it has done best for over a decade, innovate targeted and clinically validated assessment tools for individuals with Parkinson's, and deliver them globally.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.